Tyche Industries Limited

Equities

TYCHE6

INE443B01012

Pharmaceuticals

Delayed Bombay S.E. 08:52:41 26/06/2024 BST 5-day change 1st Jan Change
178.8 INR +0.56% Intraday chart for Tyche Industries Limited +0.45% -3.87%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Tyche Industries Limited Recommends Final Dividend CI
Tyche Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Tyche Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Tyche Industries to Undertake Maintenance Activities at Kakinada, India Plant MT
Tyche Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Tyche Industries Limited Announces Resignation of Boosa Eshwar, Independent Director CI
Tyche Industries Board Declares Dividend for Fiscal 2023 MT
Tyche Industries Limited Approves Dividend on the Equity Shares for the Financial Year Ended March 31, 2023 CI
Tyche Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Tyche Industries Limited Announces Management Changes CI
Tyche Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Tyche Industries Limited Recommends Final Dividend CI
Tyche Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Tyche Industries Declares Dividend for Fiscal 2023 MT
Tyche Industries Limited Declares Dividend for the Financial Year 2021-22 CI
Tyche Industries Limited Approves Dividend for the Financial Year Ended March 31, 2022 CI
Tyche Industries Limited Recommends Dividend for the Financial Year Ended March 31, 2022 CI
Tyche Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Tyche Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Tyche Industries Limited Recommends Final Dividend CI
Tyche Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Tyche Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Tyche Industries Limited Approves Dividend for the Financial Year Ended March 31, 2021 CI
Tyche Industries Limited Proposes Dividend for the Financial Year Ended March 31, 2021 CI
Tyche Industries Limited Announces to Pay Environmental Compensation of INR 6,336,400 to Central Pollution Control Board CI
Chart Tyche Industries Limited
More charts
Tyche Industries Limited is an India-based company engaged in manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates of APIs. The Company operates through the Bulk Drugs segment. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Succinate, Tamsulosin HCI, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Fumarate, Atazanavir, Rupatadine Fumarate, Glucosamine HCI, Glucosamine Sulfate KCL, Glucosamine Sulfate NaCl, Nitrofurantoin Monohydrate, Nitrofurantoin Anhydrous and Nitrofurantoin Macrocrystal and others. Its intermediates include 4-(3,4-Dichlorophenyl)-1-tetralone, 1-Benzylpiperidine-4-Carboxaldehyde (BPCA), 3-Hydroxymethyl quinuclidine Hcl, and others. Its chiral intermediates include S-(+)-3-Quinuclidinol, R-(-)-3-Quinuclidinol and others. The Company's nutraceuticals include Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride and Glucosamine Sulfate Sodium Chloride.
More about the company
  1. Stock Market
  2. Equities
  3. TYCHE6 Stock
  4. News Tyche Industries Limited
  5. Tyche Industries Board Declares Dividend for Fiscal 2023